Gadolinium pharmacokinetics of chronic myocardial infarcts: Implications for late gadolinium-enhanced infarct imaging

Journal of Magnetic Resonance Imaging

Volumn 30, Issue 4, 2009, Pages 763-770

  Goldfarb, James W ^a,b   Arnold, Sheeba ^a   Roth, Marguerite ^a  

^a ST FRANCIS HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Gadolinium; Heart; Magnetic resonance imaging; Myocardial infarction

Indexed keywords

GADODIAMIDE;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHRONIC DISEASE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ROC CURVE;

EID: 70349696520     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21901     Document Type: Article

References (34)

1. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28. (Pubitemid 32056497)
2. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167. (Pubitemid 34084313)
3. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453. (Pubitemid 30832880)
4. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-1683. (Pubitemid 30736935)
5. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105:224-229.
6. Kim RJ, Shah DJ, Judd RM. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003;5:505-514.
7. Simonetti OP, Kim RJ, Fieno DS, et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223. (Pubitemid 32151298)
8. Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology 2004;233:921-926.
9. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383. (Pubitemid 34116807)
10. de Roos A, Doornbos J, van der Wall EE, van Voorthuisen AE. MR imaging of acute myocardial infarction: value of Gd-DTPA. AJR Am J Roentgenol 1988;150:531-534. (Pubitemid 18075385)
11. Garcia-Dorado D, Oliveras J, Gili J, et al. Analysis of myocardial oedema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 1993;27:1462-1469. (Pubitemid 23265067)
12. Tilak GS, Hsu LY, Hoyt RF Jr, Arai AE, Aletras AH. In vivo T2-weighted magnetic resonance imaging can accurately determine the ischemic area at risk for 2-day-old nonreperfused myocardial infarction. Invest Radiol 2008;43:7-15.
13. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-1991.
14. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708. (Pubitemid 29249466)
15. Sandstede JJ, Beer M, Lipke C, et al. Time course of contrast enhancement patterns after Gd-BOPTA in correlation to myocardial infarction and viability: a feasibility study. J Magn Reson Imaging 2001;14:789-794. (Pubitemid 33101539)
16. Grebe O, Paetsch I, Kestler HA, et al. Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction. J Cardiovasc Magn Reson 2003;5:575-587. (Pubitemid 37420772)
17. Petersen SE, Mohrs OK, Horstick G, et al. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 2004;6:541-548. (Pubitemid 39277125)
18. Klein C, Nekolla SG, Balbach T, et al. The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 2004;20:588-593. (Pubitemid 39313734)
19. Goldfarb JW, Mathew ST, Reichek N. Quantitative breath-hold monitoring of myocardial gadolinium enhancement using inversion recovery TrueFISP. Magn Reson Med 2005;53:367-371. (Pubitemid 40171051)
20. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193. (Pubitemid 40139730)
21. Messroghli DR, Niendorf T, Schulz-Menger J, Dietz R, Friedrich MG. T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson 2003;5:353-359. (Pubitemid 36569954)
22. Scheffler K, Hennig J. T(1) quantification with inversion recovery TrueFISP. Magn Reson Med 2001;45:720-723.
23. Schmitt P, Griswold MA, Jakob PM, et al. Inversion recovery TrueFISP: quantification of T(1), T(2), and spin density. Magn Reson Med 2004;51:661-667.
24. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809. (Pubitemid 28213624)
25. Marks B, Mitchell DG, Simelaro JP. Breath-holding in healthy and pulmonary-compromised populations: effects of hyperventilation and oxygen inspiration. J Magn Reson Imaging 1997;7:595-597. (Pubitemid 28360881)
26. Liu CY, Wieben O, Brittain JH, Reeder SB. Improved delayed enhanced myocardial imaging with T2-Prep inversion recovery magnetization preparation. J Magn Reson Imaging 2008;28:1280-1286.
27. Kim D, Lee VS, Srichai MB. Improved visualization of non-transmural scar using slice-selective inversion-recovery delayed contrast-enhanced MRI: a preliminary report. NMR Biomed 2007;20:121-127. (Pubitemid 46470934)
28. Foo TK, Wolff SD, Gupta SN, Kraitchman DL. Enhanced viability imaging: improved contrast in myocardial delayed enhancement using dual inversion time subtraction. Magn Reson Med 2005;53:1484-1489.
29. Kellman P, Chung YC, Simonetti OP, McVeigh ER, Arai AE. Multicontrast delayed enhancement provides improved contrast between myocardial infarction and blood pool. J Magn Reson Imaging 2005;22:605-613. (Pubitemid 41572712)
30. Saranathan M, Rochitte CE, Foo TK. Fast, three-dimensional free-breathing MR imaging of myocardial infarction: a feasibility study. Magn Reson Med 2004;51:1055-1060. (Pubitemid 38580620)
31. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567.
32. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008;10:54.
33. Prasad PV, Goldfarb J, Sundaram C, Priatna A, Li W, Edelman RR. Captopril MR renography in a swine model: toward a comprehensive evaluation of renal arterial stenosis. Radiology 2000;217:813-818. (Pubitemid 30952197)
34. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211:101-110.